The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Neuropathic Pain
Interventions
DRUG

GW493838

Trial Locations (32)

12205

GSK Clinical Trials Call Center, Albany

16601

GSK Clinical Trials Call Center, Altoona

16635

GSK Clinical Trials Call Center, Duncansville

27103

GSK Clinical Trials Call Center, Winston-Salem

28803

GSK Clinical Trials Call Center, Asheville

32119

GSK Clinical Trials Call Center, South Daytona

33024

GSK Clinical Trials Call Center, Pembroke Pines

33308

GSK Clinical Trials Call Center, Fort Lauderdale

33407

GSK Clinical Trials Call Center, West Palm Beach

33409

GSK Clinical Trials Call Center, Palm Beach

33410

GSK Clinical Trials Call Center, Palm Beach Gardens

33701

GSK Clinical Trials Call Center, St. Petersburg

33916

GSK Clinical Trials Call Center, Fort Myers

35801

GSK Clinical Trials Call Center, Huntsville

40202

GSK Clinical Trials Call Center, Louisville

40205

GSK Clinical Trials Call Center, Louisville

40503

GSK Clinical Trials Call Center, Lexington

47712

GSK Clinical Trials Call Center, Evansville

53792

GSK Clinical Trials Call Center, Madison

70433

GSK Clinical Trials Call Center, Covington

71913

GSK Clinical Trials Call Center, Hot Springs

72205

GSK Clinical Trials Call Center, Little Rock

74104

GSK Clinical Trials Call Center, Tulsa

75080

GSK Clinical Trials Call Center, Richardson

80304

GSK Clinical Trials Call Center, Boulder

89052

GSK Clinical Trials Call Center, Henderson

92037

GSK Clinical Trials Call Center, La Jolla

92056

GSK Clinical Trials Call Center, Oceanside

98405

GSK Clinical Trials Call Center, Tacoma

02115

GSK Clinical Trials Call Center, Boston

03766

GSK Clinical Trials Call Center, Lebanon

07450

GSK Clinical Trials Call Center, Ridgewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY